DA-1726

FDA approves NeuroBo’s DA-1726 application to begin Phase I trial
Clinical Trials Arena
Fri, 02/2/24 - 11:55 am
NeuroBo Pharmaceuticals
DA-1726
FDA
clinical trials
obesity
NeuroBo signs license deal with Dong-A ST to develop two drug candidates
Pharmaceutical Business Review
Fri, 09/16/22 - 10:16 am
NeuroBio
Dong-A ST
drug development
DA-1241
DA-1726
cardiometabolic diseases